* Inari Medical Inc NARI.OQ reported a quarterly adjusted
loss
of 8 cents per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -11 cents. The mean expectation of ten analysts for the
quarter was for earnings of one cent per share. Wall Street
expected results to range from -6 cents to 8 cents per share.
* Revenue rose 22.6% to $132.09 million from a year ago;
analysts
expected $131.79 million.
* Inari Medical Inc's reported EPS for the quarter was a
loss of 8
cents.
* The company reported a quarterly loss of $4.67 million.
* Inari Medical Inc shares had fallen by 10.3% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 66.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Inari Medical Inc
is $74.50
This summary was machine generated from LSEG data February 29 at
06:13 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.01 -0.08 Missed
Sep. 30 2023 0.00 0.05 Beat
Jun. 30 2023 -0.13 0.04 Beat
Mar. 31 2023 -0.23 -0.04 Beat